Immunome, Inc. (IMNM) Reports Q2 Loss, Beats Revenue Estimates

Immunome, Inc. (IMNM) came out with a quarterly loss of $0.5 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to a loss of $0.49 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.85%. A quarter ago, it was expected that this company would post a loss of $0.66 per share when it actually produced a loss of $0.52, delivering a surprise of +21.21%.Over the last four quarters, the company has surpass ...